Paul J. Clancy, Executive VP and CFO at BIOGEN INC. (BIIB), sold 19,782 shares at $291.55 ($5.8M) on 2017-03-13, disclosed to the SEC on 2017-03-14.
Open-market sale of $5.8M BIIB by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $291.55 | 9,891 | $2.9M | 50.0% |
| 2 | $291.55 | 9,891 | $2.9M | 50.0% |
| Total | $291.55 avg | 19,782 | $5.8M | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2013-09-19 | $6.6M | — | Filing → |